Passage BIO, Inc. (PASG) Form 10-Q Quarterly Reports
Passage BIO, Inc. (PASG) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: PASG
CIK: 1787297
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
KPMG LLP
Auditor SinceSince 12/31/2019 12:00:00 AM
Lead Engagement PartnerVincent Drozd
Audit LocationPhiladelphia, Pennsylvania, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| EFFECT | 2026-10-09 | — | EFFECT Filing | 9999999995-26-003198 | View SEC Doc Filr Page |
| 424B3 | 2026-10-09 | — | 424B3 | 0001140361-26-039280 | View SEC Doc Filr Page |
| S-4/A | 2026-10-08 | — | S-4/A | 0001140361-26-039151 | View SEC Doc Filr Page |
| S-4/A | 2026-10-05 | — | S-4/A | 0001140361-26-038646 | View SEC Doc Filr Page |
| S-4/A | 2026-09-21 | — | S-4/A | 0001140361-26-037256 | View SEC Doc Filr Page |
| S-4/A | 2026-09-03 | — | S-4A | 0001140361-26-035517 | View SEC Doc Filr Page |
| 425 | 2026-09-03 | — | 425 | 0001140361-26-035516 | View SEC Doc Filr Page |
| 8-K | 2026-09-03 | 2026-09-02 | 8-K | 0001140361-26-035515 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0000902664-26-003492 | View SEC Doc Filr Page |
| 10-Q | 2026-08-10 | 2026-06-30 | 10-Q | 0001104659-26-093021 | View SEC Doc Filr Page |
| 425 | 2026-07-22 | — | 425 | 0001140361-26-029196 | View SEC Doc Filr Page |
| S-4 | 2026-07-21 | — | S-4 | 0001140361-26-029162 | View SEC Doc Filr Page |
| SCHEDULE 13D | 2026-07-02 | — | SCHEDULE 13D Filing | 0000902664-26-003000 | View SEC Doc Filr Page |
| 4 | 2026-06-29 | 2026-06-25 | 4 Filing | 0000902664-26-002945 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-06-25 | — | SCHEDULE 13G Filing | 0001957912-26-000025 | View SEC Doc Filr Page |
| 425 | 2026-06-24 | — | 425 | 0001104659-26-077350 | View SEC Doc Filr Page |
| 425 | 2026-06-24 | — | 425 | 0001104659-26-077312 | View SEC Doc Filr Page |
| 8-K | 2026-06-24 | 2026-06-23 | FORM 8-K | 0001104659-26-077306 | View SEC Doc Filr Page |
| 8-K | 2026-05-27 | 2026-05-21 | 8-K | 0001104659-26-066956 | View SEC Doc Filr Page |
| 8-K | 2026-05-26 | 2026-05-19 | FORM 8-K | 0001104659-26-065991 | View SEC Doc Filr Page |
| 4 | 2026-05-21 | 2026-05-19 | 4 Filing | 0001986720-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-05-21 | 2026-05-19 | 4 Filing | 0001706400-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-05-21 | 2026-05-19 | 4 Filing | 0001303811-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-05-21 | 2026-05-19 | 4 Filing | 0001677141-26-000006 | View SEC Doc Filr Page |
| 4 | 2026-05-21 | 2026-05-19 | 4 Filing | 0001280044-26-000002 | View SEC Doc Filr Page |